We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$13.3B
AUM Growth
+$1.82B
Cap. Flow
+$65.9M
Cap. Flow %
0.5%
Top 10 Hldgs %
32.36%
Holding
350
New
21
Increased
125
Reduced
153
Closed
21

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$72.8M
2
ABBV icon
AbbVie
ABBV
+$59.8M
3
PG icon
Procter & Gamble
PG
+$53.3M
4
VZ icon
Verizon
VZ
+$26.4M
5
AVGO icon
Broadcom
AVGO
+$19.9M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$79.9M
2
MCD icon
McDonald's
MCD
+$64.5M
3
EL icon
Estee Lauder
EL
+$57.4M
4
O icon
Realty Income
O
+$20.5M
5
AAPL icon
Apple
AAPL
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Healthcare 15.36%
3 Financials 13.42%
4 Consumer Staples 9.92%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZTA icon
201
Azenta
AZTA
$1.48B
$2.34M 0.02%
52,917
-179
-0.3% -$6.85K
MPWR icon
202
Monolithic Power Systems
MPWR
$68.9B
$2.33M 0.02%
9,823
-10,727
-52% -$2.17M
ENSG icon
203
The Ensign Group
ENSG
$10.7B
$2.32M 0.02%
+55,386
New +$2.2M
STZ icon
204
Constellation Brands
STZ
$23.2B
$2.29M 0.02%
13,064
-2,244
-15% -$374K
DEO icon
205
Diageo
DEO
$53.6B
$2.27M 0.02%
16,916
-4,290
-20% -$589K
HRC
206
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.23M 0.02%
20,333
-1,300
-6% -$136K
NTAP icon
207
NetApp
NTAP
$37.2B
$2.23M 0.02%
50,198
+41,318
+465% +$1.78M
SHW icon
208
Sherwin-Williams
SHW
$89.8B
$2.2M 0.02%
11,433
BC icon
209
Brunswick
BC
$5.28B
$2.13M 0.02%
33,274
-1,681
-5% -$83.8K
REXR icon
210
Rexford Industrial Realty
REXR
$8.19B
$2.13M 0.02%
+51,387
New +$2.06M
PM icon
211
Philip Morris
PM
$295B
$2.13M 0.02%
30,361
-14,299
-32% -$1.04M
OLED icon
212
Universal Display
OLED
$4.19B
$2.12M 0.02%
+14,161
New +$2.08M
CPK icon
213
Chesapeake Utilities
CPK
$3.21B
$2.06M 0.02%
24,501
-352
-1% -$30.6K
HSY icon
214
Hershey
HSY
$36.6B
$2.04M 0.02%
15,779
+467
+3% +$62.8K
JOUT icon
215
Johnson Outdoors
JOUT
$505M
$2.04M 0.02%
22,365
-6,296
-22% -$450K
CL icon
216
Colgate-Palmolive
CL
$74.4B
$2M 0.02%
27,231
+50
+0.2% +$3.55K
EXPO icon
217
Exponent
EXPO
$3.24B
$1.99M 0.02%
+24,574
New +$1.77M
AVNT icon
218
Avient
AVNT
$4.19B
$1.96M 0.01%
74,598
-100
-0.1% -$2.32K
DHI icon
219
D.R. Horton
DHI
$42.3B
$1.93M 0.01%
34,811
+822
+2% +$39.8K
JBSS icon
220
John B. Sanfilippo & Son
JBSS
$972M
$1.89M 0.01%
22,145
+12,327
+126% +$1.05M
NDSN icon
221
Nordson
NDSN
$17.3B
$1.86M 0.01%
9,804
-45
-0.5% -$7.63K
CABO icon
222
Cable One
CABO
$212M
$1.83M 0.01%
1,033
-200
-16% -$358K
BF.B icon
223
Brown-Forman Class B
BF.B
$13.1B
$1.81M 0.01%
28,393
-641
-2% -$40.9K
AAON icon
224
Aaon
AAON
$7.77B
$1.77M 0.01%
49,008
-438
-0.9% -$14.7K
ORCL icon
225
Oracle
ORCL
$423B
$1.76M 0.01%
31,912
-745
-2% -$39.5K

Similar funds

Bahl & Gaynor's Q2 2020 Portfolio in Review

As of Q2 2020, Bahl & Gaynor held 350 positions worth $13.3B, up 16% from $11.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q2 2020 filing shows 21 new, 125 increased, 153 reduced and 21 closed positions. Its largest new stake was Otis Worldwide: 90,609 shares worth $5.15M. The largest sale was Pfizer, an estimated $79.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q2 2020 buy was Otis Worldwide: 90,609 shares worth $5.15M.
  • Bahl & Gaynor added most to Merck in Q2 2020, an estimated $72.8M increase.
  • Bahl & Gaynor's biggest Q2 2020 reduction was Pfizer, cutting an estimated $79.9M.
  • Bahl & Gaynor fully exited Interparfums in Q2 2020, selling an estimated $4.84M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $13.3B portfolio in Q2 2020.
  • Bahl & Gaynor opened 21 new positions and closed 21 in Q2 2020.
  • Bahl & Gaynor's portfolio value rose 16% quarter-over-quarter to $13.3B.

Based on Bahl & Gaynor's 13F filing for Q2 2020, filed 13 Aug 2020.